Amyloid-related imaging abnormalities in AβPP duplication carriers

Journal of Alzheimer's Disease

Volumn 37, Issue 4, 2013, Pages 789-793

  Chamard, Ludivine ^a   Wallon, David ^b   Pijoff, Alexa ^a   Berger, Eric ^a   Viennet, Gabriel ^a   Hannequin, Didier ^b   Magnin, Eloi ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Alzheimer's disease; amyloid burden; APOE; A PP duplication; cerebral amyloid angiopathy related inflammation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE;

ADULT; APOE GENE; ARTICLE; BRAIN BIOPSY; CASE REPORT; CEREBRAL AMYLOID ANGIOPATHY RELATED INFLAMMATION; ENCEPHALITIS; FEMALE; FOLLOW UP; GENE; GENOTYPE; HUMAN; HUMAN TISSUE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

ALZHEIMER'S DISEASE; AMYLOID BURDEN; APOE; AΒPP DUPLICATION; CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION;

AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; PEDIGREE;

EID: 84892734675     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130629     Document Type: Article

References (17)

1. Knudsen KA, Rosand J, Karluk D, Greenberg SM (2001) Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston criteria. Neurology 56, 537-539.
2. Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MS (2004) Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62, 494-497.
3. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, FroschMP, Greenberg SM(2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68, 1411-1416.
4. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu, Liu YE, Gregg K, Brashear HR, Kinney GG, Black R, Grundman M (2012) Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: A retrospective analysis. Lancet Neurol 11, 241-249.
5. Guyant-Marechal I, Berger E, Laquerrìere A, Rovelet- Lecrux A, Viennet G, Frebourg T, Rumbach L, Campion D, Hannequin D (2008) Intrafamilial diversity of phenotype associated with app duplication. Neurology 71, 1925-1926.
6. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, SudlowCL,WardlawJM, Al-Shahi Salman R (2009) Improving interrater agreement about microbleeds: Development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 40, 94-99.
7. Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA (2011) Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry 82, 20-26.
8. McHugh JC, Ryan AM, Lynch T, Dempsey E, Stack J, Farrell MA, Kelly PJ (2007) Steroid-responsive recurrent encephalopathy in a patient with cerebral amyloid angiopathy. Cerebrovasc Dis 23, 66-69.
9. Kimura A, Sakurai T, Yoshikura N, Hayashi Y, Takemura M, Takahashi H, Inuzuka T (2013) Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation. J Neuroinflammation 10, 39.
10. Drzezga A, Grimmer T, Henriksen G, Muhlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschlager A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A (2009) Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 72, 1487-1494.
11. Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, GreggKM,Liu E, Lieberburg I, Schenk D, Black R, Grundman M, Bapineuzumab for the 201 Clinical Trial, Investigators (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73, 2061-2070.
12. Sperling RA, Jack CR Jr., Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research RoundtableWorkgroup. Alzheimers Dement 7, 367- 385.
13. Pottier C,Wallon D, Lecrux AR, Maltete D, Bombois S, Jurici S, Frebourg T, Hannequin D, Campion D (2012) Amyloid- protein precursor gene expression in Alzheimer's disease and other conditions. J Alzheimers Dis 28, 561-566.
14. Biffi A, Plourde A, Shen Y, Onofrio R, Smith EE, Frosch M, Prada CM, Gusella J, Greenberg SM, Rosand J (2010) Screening for familial APP mutations in sporadic cerebral amyloid angiopathy. PLoS One 5, e13949.
15. Wallon D, Rousseau S, Rovelet-Lecrux A, Quillard-Muraine M, Guyant-Maŕechal L, Martinaud O, Pariente J, Puel M, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonnìere C, Thomas-Ant'erion C, Paquet C, Moreaud O, Gabelle A, Sellal F, Sauv'ee M, Laquerrìere A, Duyckaerts C, Delisle MB, Streichenberger N, Lannes B, Frebourg T, Hannequin D, Campion D, collaborators of GMAJ, project (2012) The French series of autosomal dominant early onset Alzheimer's disease cases: Mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis 30, 847-856.
16. Sakai K, Hayashi S, Sanpei K,Yamada M,TakahashiH(2012) Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy-related inflammation. Neuropathology 32, 551-556.
17. Charidimou A, Peeters A, FoxZ, Gregoire SM,Vandermeeren Y, Laloux P, Jager HR, Baron JC,Werring DJ (2012) Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: Multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke 43, 2324-2330.